116 related articles for article (PubMed ID: 23167431)
1. Chemotherapy through a combination of fasting and chronopharmacology.
Vijayarathna S; Sasidharan S
Asian Pac J Cancer Prev; 2012; 13(9):4847-8. PubMed ID: 23167431
[No Abstract] [Full Text] [Related]
2. Cancer chronotherapeutics: experimental, theoretical, and clinical aspects.
Ortiz-Tudela E; Mteyrek A; Ballesta A; Innominato PF; Lévi F
Handb Exp Pharmacol; 2013; (217):261-88. PubMed ID: 23604483
[TBL] [Abstract][Full Text] [Related]
3. [Chronopharmacology and chronotherapy of cancers].
Lévi F
Pathol Biol (Paris); 1996 Sep; 44(7):631-44. PubMed ID: 8977920
[TBL] [Abstract][Full Text] [Related]
4. Molecular Aspects of Circadian Pharmacology and Relevance for Cancer Chronotherapy.
Ozturk N; Ozturk D; Kavakli IH; Okyar A
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039812
[TBL] [Abstract][Full Text] [Related]
5. [Molecular basis of choronopharmacology].
Koyanagi S
Seikagaku; 2014 Dec; 86(6):774-7. PubMed ID: 25675816
[No Abstract] [Full Text] [Related]
6. Chronotherapy and the molecular clock: Clinical implications in oncology.
Innominato PF; Lévi FA; Bjarnason GA
Adv Drug Deliv Rev; 2010 Jul; 62(9-10):979-1001. PubMed ID: 20600409
[TBL] [Abstract][Full Text] [Related]
7. [Various problems of chronopharmacology and chronotherapy at present].
Zaslavskaia RM; Olevskiĭ IKh; Duda SG
Ter Arkh; 1985; 57(12):89-93. PubMed ID: 4089775
[No Abstract] [Full Text] [Related]
8. Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability.
Lévi F; Karaboué A; Gorden L; Innominato PF; Saffroy R; Giacchetti S; Hauteville D; Guettier C; Adam R; Bouchahda M
Cancer Chemother Pharmacol; 2011 Feb; 67(2):339-48. PubMed ID: 20401611
[TBL] [Abstract][Full Text] [Related]
9. [Chronotherapy in oncology. The place of ambulatory services].
Bey C; Willemot JM
Soins; 1998 May; (625):24. PubMed ID: 9668918
[No Abstract] [Full Text] [Related]
10. [Chronotherapy in oncology. Perspectives. Quality of care, quality of life].
Teller AM
Soins; 1998 May; (625):23. PubMed ID: 9668917
[No Abstract] [Full Text] [Related]
11. [The significance of chronopharmacology for oncology].
Hallek M; Lévi F; Haen E; Emmerich B
Onkologie; 1989 Oct; 12(5):230-8. PubMed ID: 2685689
[TBL] [Abstract][Full Text] [Related]
12. [Chronochemotherapy for cancer].
Akazawa S
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1191-202. PubMed ID: 9279336
[TBL] [Abstract][Full Text] [Related]
13. Cancer research. Can fasting blunt chemotherapy's debilitating side effects?
Couzin J
Science; 2008 Aug; 321(5893):1146-7. PubMed ID: 18755948
[No Abstract] [Full Text] [Related]
14. Circadian chronotherapy for human cancers.
Lévi F
Lancet Oncol; 2001 May; 2(5):307-15. PubMed ID: 11905786
[TBL] [Abstract][Full Text] [Related]
15. Poorly specified fasting conditions in clinical research could lead to treatment failure.
Lubberman FJE; Burger D; van Erp NP
Lancet Oncol; 2017 May; 18(5):571-573. PubMed ID: 28495277
[No Abstract] [Full Text] [Related]
16. Fasting plus tyrosine kinase inhibitors in cancer.
Caffa I; Longo VD; Nencioni A
Aging (Albany NY); 2015 Dec; 7(12):1026-7. PubMed ID: 26645151
[No Abstract] [Full Text] [Related]
17. The Gompertzian view: Norton honored for role in establishing cancer treatment approach.
Schmidt C
J Natl Cancer Inst; 2004 Oct; 96(20):1492-3. PubMed ID: 15494594
[No Abstract] [Full Text] [Related]
18. Chronotherapeutic drug delivery.
Librodo P; Buckley M; Luk M; Bisso A
J Infus Nurs; 2012; 35(5):329-34. PubMed ID: 22955155
[TBL] [Abstract][Full Text] [Related]
19. [Fasting and chemotherapy: what do we tell our patients?].
Frigeri M
Rev Med Suisse; 2015 Dec; 11(499):2404-5. PubMed ID: 26852558
[No Abstract] [Full Text] [Related]
20. Chronotherapeutics: the relevance of timing in cancer therapy.
Lévi F
Cancer Causes Control; 2006 May; 17(4):611-21. PubMed ID: 16596317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
